The epidemiological investigation of non-alcoholic fatty liver in patients with cardiovascular disease risk

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-12002000

Enrollment

Unknown

Registered

2012-03-14

Start date

2012-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

A:liver biopsy

B:liver biopsy

C:Cardiac Coronary CTA

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years old; 2. patients will undergoing liver biopsy; 3. patients signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. >20 g per day in men and 10 g per day in wome; 2. Patients with positive hepatitis B surface antigen, antibody against hepatitis C virus and antinuclear antibody titre >1/160; 3. Patients had autoimmune or genetically induced (hemochromatosis, Wilson's disease or a1-antitrypsin deficiency) liver disease; 4. injection drug users.

Design outcomes

Primary

Measure	Time frame
liver function;blood routine;biochemistry variable;computed tomography;Hemorheology;Carotid artery ultrasound;	—

Countries

China

Contacts

Public ContactDongfeng Chen

chendf1981@126.com+86 13883032812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026